{
    "nctId": "NCT02410044",
    "briefTitle": "Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer",
    "officialTitle": "Open-labeled, Multicenter, Non-interventional Prospective PRO/QoL Registry for Patients With Osteoprotective Treatment for Bone Metastases of Breast or Prostate Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Prostate Cancer, Bone Metastases",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 500,
    "primaryOutcomeMeasure": "Patient Reported Outcomes (PRO) regarding bone pain and the impact of bone pain on quality of life and daily activities in patients with bone metastases treated with osteoprotective agents.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically confirmed metastatic breast or prostate cancer\n* Start of first systemic osteoprotective treatment\n* Ability to read and understand German\n* Written informed consent\n\nExclusion Criteria:\n\n\u2022 None",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}